Navigation Links
NIH media availability: Protein linked to increased risk of heart failure and death in older adults
Date:8/29/2012

WHAT: A protein known as galectin-3 can identify people at higher risk of heart failure, according to new research supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health. This research is based on work from the NHLBI's Framingham Heart Study, which began in 1948 and has been the leading source of research findings about heart disease risk factors.

"Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community," will be published online August 29 in the Journal of the American College of Cardiology and in the October 2 print issue.

Heart failure occurs when the heart cannot fill with enough blood and/or pump enough blood to meet the body's needs. Galactin-3 has recently been associated with cardiac fibrosis, a condition in which scar tissue replaces heart muscle, and cardiac fibrosis plays an important role in the development of heart failure.

Heart failure carries enormous risk for death or a lifetime of disability and often there are few warning signs of impending heart failure. Measuring levels of galectin-3 in the blood may offer a way to identify high-risk individuals who could benefit from treatments to prevent debilitating heart failure and death. Early identification of predisposed individuals would allow treatment to begin long before heart failure develops and could help people at high risk for heart failure to live longer, more active lives.

Galectin-3 levels were measured in 1996-1998 as part of a routine examination of 3,353 participants enrolled in the Offspring Cohort of the Framingham Heart Study. At the time of measurement the average age of the participants was 59 years old. During an average follow-up of 11 years, 166 participants (5.1 percent) had a first heart failure event. Among the 25 percent of people with the highest galectin-3 levels (ranging from 15.4 to 52.1 nanograms per milliliter) the annual rate of heart failure was 12 per 1,000 people compared with 3 per 1,000 people for the 25 percent of participants with the lowest galectin-3 levels (ranging from 3.9 to 12 nanograms per milliliter). Fifty-three percent of participants were women.

Spironolactone and other related drugs believed to counteract cardiac fibrosis have been shown to improve outcomes in heart failure patients. Future research will be needed to determine whether treatment with these or other drugs can benefit healthy patients with elevated galectin-3 levels.


'/>"/>
Contact: NHLBI Communications Office
NHLBI_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung and Blood Institute
Source:Eurekalert

Related biology technology :

1. ASAE, TMG Custom Media Collaborate to Launch New Print-Plus-Digital Strategy for Associations Now Magazine
2. PhoenixSongs Biologicals, Inc. Announces Enhanced Neural Lineage-specific Cell Culture Media Products Release
3. Mold Threats Debby Flood Victims, Molderizer Reaches Out With Non-Toxic Mold Remediation Products
4. Air Innovations’ Environmental Control Projects Featured in Trade Media
5. Californians Take One Step Closer to Directly Accessing Physical Therapy Services for Immediate Treatment
6. Profit Lifter for Pro Mold Removers: Molderizer Introduces Remediation Product Like No Other
7. The Scientist Magazine’s 2012 Multimedia Awards—Call for Entries
8. Big Saver: Molderizer Offers 30% Mold Remediation Products Price Cut
9. Nanoscale magnetic media diagnostics by rippling spin waves
10. Protein that helps tumor blood vessels mature could make cancer drugs more effective
11. Frost & Sullivan Recognizes MicroProtein Technologies for its Path-Breaking Production Technology for Recombinant Proteins in Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2017)... ... 19, 2017 , ... In response to the strong base of evidence supporting ... announces the release of their Gait Trainer 3 with an Integrated Music Therapy option. ... to aid in rehabilitating individuals with cerebral palsy, traumatic brain injury, stroke and Parkinson’s ...
(Date:5/18/2017)... ... May 18, 2017 , ... ... The Tapas Cooking Challenge is a two-hour team-building package designed for groups of ... by Chef Jodi Abel, which include items, such as Blackened Shrimp with Edamame ...
(Date:5/18/2017)... ... May 17, 2017 , ... ... stress expertise, and further enhances its scientific power by providing investigators access ... Ph.D., has agreed to join the scientific advisory board. “We are committed ...
(Date:5/18/2017)... ... 17, 2017 , ... HOLLOWAY AMERICA, a leading manufacturer of ... munitions, and pharmaceutical/biotech, recently introduced The Revolution Lift™, a new precision-controlled head lift ... technology comes on the heels of HOLLOWAY’s release of the intelliVessel™, a smart ...
Breaking Biology Technology:
(Date:3/20/2017)... , March 20, 2017 At this year,s ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand ... is this year,s CeBIT partner country. At the largest German biometrics ... in use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics ... ...
(Date:3/16/2017)... Against identity fraud with DERMALOG solutions "Made in Germany "  ... ... solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. ... ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
Breaking Biology News(10 mins):